Insulin and ANGPTL4 are key, opposing regulators of LPL activity, insulin enhances LPL, whereas ANGPTL4 inhibits it, and LPL activity is closely linked to circulating free fatty acid levels and the development of hepatic steatosis. This evidence concerns the gene ANGPTL4 and fatty liver disease.